[1]
B. Dwipoyono, S. Choirunisa, M. Nadjib, and A. C. Sjaaf, “COST ANALYSIS OF TAXANE-BASED AND CISPLATIN-BASED CHEMOTHERAPY REGIMENS FOR EPITHELIAL OVARIAN CANCER IN DHARMAIS NATIONAL CANCER HOSPITAL”, Int J App Pharm, vol. 9, pp. 172–175, Oct. 2017.